Fusion-inhibiting Entry-inhibiting influenza anti-viral drugs and the APA Assay and other proprietary tests for fibromyalgia, lupus, Sjogren's syndrome, juvenile rheumatoid arthritis, Gulf War Syndrome, Lassa fever and other disorders are being developed by Autoimmune Technologies of New Orleans.